Commemorating the 20th anniversary of the discovery of epidermal growth factor receptor mutation in lung cancer: Translational research at its best

Abstract

The discovery of epidermal growth factor receptor mutations in non–small cell lung cancer (NSCLC) launched the era of personalized medicine in advanced NSCLC, which led to a dramatic shift in the therapeutic landscape of this disease.